ACE2 and endothelial dysfunction: In our early and less severe kidney model, amelioration of endothelial dysfunction by soluble ACE2 may be sufficient to reduce albuminuria, while more severe renal lesions cannot be accessed by soluble ACE2 that is both too large to be filtered at the glomerulus and fails to modulate the highly-active intra-renal RAAS [25].